Abiopharma

New Form 6-K - PolyPid Ltd. Filed: 2025-08-12 AccNo: 0001213900-25-074642 Size: 30 KB

Integer Holdings Corporation - Integer to Present at 2025 Wells Fargo Healthcare Conference on Sept. 4

CoyaTherapeutics - Coya Therapeutics Reports Second Quarter Financial Results and Provides a Corporate Update

New Form 8-K - Elicio Therapeutics, Inc. Filed: 2025-08-12 AccNo: 0001601485-25-000114 Size: 1 MB Item 8.01: Other Events

A New Press Release from Elicio Therapeutics

New Form 8-K - 180 Life Sciences Corp. Filed: 2025-08-12 AccNo: 0001213900-25-074637 Size: 271 KB Item 7.01: Regulation FD Disclosure Item 8.01: Other Events Item 9.01: Financial Statements and Exhibits

New Form 8-K - Monopar Therapeutics Filed: 2025-08-12 AccNo: 0001437749-25-026043 Size: 183 KB Item 2.02: Results of Operations and Financial Condition Item 9.01: Financial Statements and Exhibits

Nanox Announces Second Quarter of 2025 Financial Resultsand Provides Business Update

New Form SC TO-T - DURECT CORP Filed: 2025-08-12 AccNo: 0001193125-25-178491 Size: 1 MB

New Form 10-Q - Monopar Therapeutics Filed: 2025-08-12 AccNo: 0001437749-25-026042 Size: 5 MB

Ecolab Inc. - Ecolab to Acquire Ovivo’s Electronics Ultra-Pure Water Business

New Form 8-K - MIRA PHARMACEUTICALS, INC. Filed: 2025-08-12 AccNo: 0001641172-25-023110 Size: 212 KB Item 8.01: Other Events

New Form 8-K - Grace Therapeutics, Inc. Filed: 2025-08-12 AccNo: 0001140361-25-030400 Size: 322 KB Item 2.02: Results of Operations and Financial Condition Item 9.01: Financial Statements and Exhibits

Taysha Gene Therapies Reports Second Quarter 2025 Financial Results and Provides Corporate Update

Ginkgo Automation Appoints Brian OSullivan as Head of Commercial to Accelerate External Growth